Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
EPA CPDat observed this chemical in 900 composition records across product categories including Construction and building materials, Industrial products, Vehicle.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 · limited confidence.
Prevalence of SORBITAN MONOOLEATE in our catalog (epa_cpdat).
Products
900
Brands
6
Typical roles
Catalog
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 900 composition records across product categories including Construction and building materials, Industrial products, Vehicle. EPA CPDat classifies this chemical for functional uses including Emulsifier, Surfactant (surface active agent), Fragrance.
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 200 mg
US
FDA
lume whole body deodorant
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 1.7 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 1080 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 19 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 0.13 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 4 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 12 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 2 mg
US
FDA
Route: RECTAL; Dosage form: SUPPOSITORY; Maximum daily exposure: 390 mg
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 50 mg
US
FDA
Route: TOPICAL; Dosage form: EMULSION; Potency: 2.5 %w/w
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 20 mg
US
FDA
Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 7 mg
US
FDA
Route: TOPICAL; Dosage form: SPRAY; Maximum daily exposure: 8 mg
US
FDA
Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Potency: NA
US
FDA
Route: TRANSDERMAL; Dosage form: SYSTEM; Potency: 2.33 mg
US
FDA
openFDA substance registry classifies this ingredient as chemical.